Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CLSI broth microdilution, and etest method

Journal of Clinical Microbiology

Volumn 53, Issue 6, 2015, Pages 1823-1830

  Kathuria, Shallu ^a   Singh, Pradeep K ^a   Sharma, Cheshta ^a   Prakash, Anupam ^a   Masih, Aradhana ^a   Kumar, Anil ^b   Meis, Jacques F ^c,d   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; ISAVUCONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA AURIS; CANDIDA DUOBUSHAEMULONII; CANDIDA FAMATA; CANDIDA HAEMULONII; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; EPSILOMETER TEST; FKS GENE; FUNGAL GENE; FUNGUS IDENTIFICATION; IN VITRO STUDY; INTERMETHOD COMPARISON; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; CANDIDIASIS; DRUG EFFECTS; GENETICS; HUMAN; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES;

CANDIDA; CANDIDA HAEMULONII; DEBARYOMYCES HANSENII;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DNA, FUNGAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84929378815     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00367-15     Document Type: Article

References (28)

1. Lachance MA, Boekhout T, Scorzetti G, Fell JW, Kurtzman CP. 2011. Candida Berkhout, p 987-1278. In Kurtzman CP, Fell JW, Boekhout T (ed), The yeasts, a taxonomic study, 5th ed. Elsevier Science B.V., Amsterdam, The Netherlands.
2. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41-44. http://dx.doi.org/10.1111/j.1348-0421.2008.00083.x.
3. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. 2009. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 48: e57-e61. http://dx.doi.org/10.1086/597108.
4. Khillan V, Rathore N, Kathuria S, Chowdhary A. 2014. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Rep http://dx.doi.org/10.1099/jmmcr.0.T00018.
5. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, Jang HC. 2011. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49:3139-3142. http://dx.doi.org/10.1128/JCM .00319-11.
6. Magobo RE, Corcoran C, Seetharam S, Govender NP. 2014. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 20:1250-1251. http://dx.doi.org/10.3201/eid2007.131765.
7. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19:1670-1673. http://dx.doi.org/10.3201/eid1910.130393.
8. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, Dinesh KR, Karim S, Singh SK, Hagen F, Meis JF. 2014. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 33:919-926. http://dx.doi.org/10.1007/s10096-013-2027-1.
9. Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, Shin MG, Suh SP, Ryang DW. 2011. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol 49:98-102. http://dx.doi.org/10.3109/13693786.2010.493563.
10. Chowdhary A, Kathuria S, Prakash A, Meis JF. 2014. Pitfalls in phenotypic identification of Candida auris and comparison of in-vitro susceptibilities using CLSI-BMD and VITEK2, abstr M-1203. Abstr 54th Intersci Conf Antimicrob Agents Chemother (ICAAC). American Society for Microbiology, Washington, DC.
11. Xu J, Ramos AR, Vilgalys R, Mitchell TG. 2000. Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J Clin Microbiol 38:1214-1220.
12. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likeli- hood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
13. Jensen RH, Arendrup MC. 2011. Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 49:549-556. http://dx.doi.org/10.1128/JCM.02071-10.
14. De Carolis E, Posteraro B, Lass-Flörl C, Vella A, Florio AR, Torelli R, Girmenia C, Colozza C, Tortorano AM, Sanguinetti M, Fadda G. 2012. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-offlight mass spectrometry. Clin Microbiol Infect 18:475-484. http://dx.doi .org/10.1111/j.1469-0691.2011.03599.x.
15. Clinical and Laboratory Standards Institute (CLSI). 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd ed. CLSI document M27-A3. CLSI, Wayne, PA.
16. Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2008. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program. J Clin Microbiol 46: 3585-3590. http://dx.doi.org/10.1128/JCM.01391-08.
17. Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. 2011. Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program. J Clin Microbiol 49: 1274-1279. http://dx.doi.org/10.1128/JCM.02437-10.
18. Pfaller MA, Messer SA, Bolmstrom A. 1998. Evaluation of Etest for determining in vitro susceptibility of yeasts isolates to amphotericin B. Diagn Microbiol Infect Dis 32:223-227.
19. Wanger A, Mills K, Nelson PW, Rex JH. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin-B resistant Candida isolates. Antimicrob Agents Chemother 39:2520. http://dx.doi.org/10.1128/AAC.39.11.2520.
20. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53:3690-3699. http://dx.doi.org/10.1128/AAC.00443-09.
21. Pfaller MA, Diekema DJ, Jones RN, Castanheira M. 2014. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria. J Clin Microbiol 52:3223-3229. http://dx.doi .org/10.1128/JCM.00782-14.
22. Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, Gómez-López A, Boekhout T. 2012. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 50:3641-3651. http://dx.doi.org/10.1128/JCM.02248-12.
23. Schrödl W, Heydel T, Schwartze VU, Hoffmann K, Grosse-Herrenthey A, Walther G, Alastruey-Izquierdo A, Rodriguez-Tudela JL, Olias P, Jacobsen ID, de Hoog GS, Voigt K. 2012. Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry. J Clin Microbiol 50:419-427. http://dx.doi.org/10.1128/JCM.01070-11.
24. Shin JH, Kim MN, Jang SJ, Ju MY, Kim SH, Shin MG, Suh SP, Ryang DW. 2012. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol 50:1852-1855. http://dx.doi.org/10.1128/JCM.06440-11.
25. Zhang L, Wang H, Xiao M, Kudinha T, Mao LL, Zhao HR, Kong F, Xu YC. 2014. The widely used ATB FUNGUS 3 automated readings in China and its misleading high MICs of Candida spp. to azoles: challenges for developing countries' clinical microbiology labs. PLoS One 9: e114004. http://dx.doi.org/10.1371/journal.pone.0114004.
26. Pfaller MA, Messer SA, Mills K, Bolmström A, Jones RN. 2001. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J Clin Microbiol 39: 4387-4389. http://dx.doi.org/10.1128/JCM.39.12.4387-4389.2001.
27. Arendrup MC, Pfaller MA, Danish Fungaemia Study Group. 2012. Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints. Antimicrob Agents Chemother 56:3965-3968. http://dx.doi.org/10.1128/AAC.00355-12.
28. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J. 2013. Interlaboratory variability of caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 57:5836-5842. http://dx.doi.org/10.1128/AAC.01519-13.